Post-market safety studies

MHRA published 16 June 2025 New Post-Market Surveillance (PMS) regulations have taken effect across Great Britain, requiring medical...

Nature 18 April 2025 Drug-related conjunctivitis can compromise ocular health and quality of life. To evaluate its epidemiology, this...

Coherent Market Insights 26 March 2025 The global Real-World Evidence (RWE) in Drug Safety market is estimated to be valued at USD 8.03...

Cureus : Published 27 March 2025 This study utilized data from the FDA Adverse Event Reporting System (FAERS) to investigate adverse drug...

BMC Pharmacology and Toxicology 26 (1) March 2025 Cefiderocol is a new drug class, which is approved to treat Gram-negative bacteria...